Titre : Régions déterminant la complémentarité

Régions déterminant la complémentarité : Questions médicales fréquentes

Termes MeSH sélectionnés :

Surveys and Questionnaires
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régions déterminant la complémentarité : Questions médicales les plus fréquentes", "headline": "Régions déterminant la complémentarité : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régions déterminant la complémentarité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-06", "dateModified": "2025-03-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régions déterminant la complémentarité" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Région variable d'immunoglobuline", "url": "https://questionsmedicales.fr/mesh/D007135", "about": { "@type": "MedicalCondition", "name": "Région variable d'immunoglobuline", "code": { "@type": "MedicalCode", "code": "D007135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02.111.570.060.425" } } }, "about": { "@type": "MedicalCondition", "name": "Régions déterminant la complémentarité", "alternateName": "Complementarity Determining Regions", "code": { "@type": "MedicalCode", "code": "D022801", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Boris I Chobrutskiy", "url": "https://questionsmedicales.fr/author/Boris%20I%20Chobrutskiy", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon, USA." } }, { "@type": "Person", "name": "George Blanck", "url": "https://questionsmedicales.fr/author/George%20Blanck", "affiliation": { "@type": "Organization", "name": "Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA." } }, { "@type": "Person", "name": "Elena S Klimtchuk", "url": "https://questionsmedicales.fr/author/Elena%20S%20Klimtchuk", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Daniele Peterle", "url": "https://questionsmedicales.fr/author/Daniele%20Peterle", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Lawreen H Connors", "url": "https://questionsmedicales.fr/author/Lawreen%20H%20Connors", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Current treatment status of IgA nephropathy in Japan: a questionnaire survey.", "datePublished": "2023-08-30", "url": "https://questionsmedicales.fr/article/37646957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10157-023-02396-0" } }, { "@type": "ScholarlyArticle", "name": "Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.", "datePublished": "2024-09-10", "url": "https://questionsmedicales.fr/article/39251506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00520-024-08858-9" } }, { "@type": "ScholarlyArticle", "name": "[The Questionnaire Survey of Japanese Practice and Environment for Targeted Radionuclide Therapy in 2021].", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36696976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.6009/jjrt.2023-1317" } }, { "@type": "ScholarlyArticle", "name": "Sequential dependencies of responses in a questionnaire survey and their effects on the reliability and validity of measurement.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36085546", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3758/s13428-022-01943-z" } }, { "@type": "ScholarlyArticle", "name": "Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.", "datePublished": "2024-11-01", "url": "https://questionsmedicales.fr/article/39486019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/64159" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes biochimiques", "item": "https://questionsmedicales.fr/mesh/D001669" }, { "@type": "ListItem", "position": 4, "name": "Région variable d'immunoglobuline", "item": "https://questionsmedicales.fr/mesh/D007135" }, { "@type": "ListItem", "position": 5, "name": "Régions déterminant la complémentarité", "item": "https://questionsmedicales.fr/mesh/D022801" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régions déterminant la complémentarité - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régions déterminant la complémentarité", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régions déterminant la complémentarité", "description": "Comment identifier les CDR dans un anticorps ?\nQuels tests révèlent la présence de CDR ?\nLes CDR peuvent-ils être visualisés ?\nQuel rôle joue la bioinformatique dans l'étude des CDR ?\nLes CDR sont-ils spécifiques à chaque anticorps ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régions déterminant la complémentarité", "description": "Quels symptômes indiquent une réponse immunitaire anormale ?\nLes CDR affectent-ils les symptômes d'infections ?\nComment les CDR influencent-ils les maladies allergiques ?\nLes CDR sont-ils liés à des symptômes de maladies auto-immunes ?\nPeut-on prédire des symptômes grâce aux CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régions déterminant la complémentarité", "description": "Comment prévenir les maladies liées aux CDR ?\nLes CDR peuvent-ils être ciblés pour la prévention ?\nQuel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?\nLes tests génétiques aident-ils à prévenir les maladies liées aux CDR ?\nComment le mode de vie influence-t-il la prévention des maladies ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régions déterminant la complémentarité", "description": "Comment les CDR sont-ils utilisés en thérapie ?\nLes traitements ciblant les CDR sont-ils efficaces ?\nQuels types de médicaments ciblent les CDR ?\nLes CDR peuvent-ils être modifiés pour améliorer les traitements ?\nQuels sont les effets secondaires des traitements ciblant les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régions déterminant la complémentarité", "description": "Quelles complications peuvent survenir avec des CDR défectueux ?\nLes CDR sont-ils impliqués dans des complications infectieuses ?\nComment les CDR affectent-ils les traitements anticancéreux ?\nLes complications liées aux CDR peuvent-elles être traitées ?\nQuels sont les risques de complications lors de thérapies ciblant les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régions déterminant la complémentarité", "description": "Quels facteurs augmentent le risque de maladies liées aux CDR ?\nL'âge influence-t-il le risque lié aux CDR ?\nLe stress a-t-il un impact sur les CDR ?\nLes infections antérieures influencent-elles les CDR ?\nComment le mode de vie affecte-t-il les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Surveys+and+Questionnaires&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les CDR dans un anticorps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les CDR sont identifiés par séquençage et analyse des structures d'anticorps." } }, { "@type": "Question", "name": "Quels tests révèlent la présence de CDR ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'affinité et de liaison aux antigènes sont utilisés pour détecter les CDR." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être visualisés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des techniques comme la cristallographie aux rayons X ou la RMN." } }, { "@type": "Question", "name": "Quel rôle joue la bioinformatique dans l'étude des CDR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La bioinformatique aide à prédire et modéliser les CDR à partir de séquences d'anticorps." } }, { "@type": "Question", "name": "Les CDR sont-ils spécifiques à chaque anticorps ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque anticorps a des CDR uniques qui déterminent sa spécificité." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réponse immunitaire anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des allergies ou des maladies auto-immunes peuvent survenir." } }, { "@type": "Question", "name": "Les CDR affectent-ils les symptômes d'infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR efficaces peuvent réduire la gravité des symptômes d'infections." } }, { "@type": "Question", "name": "Comment les CDR influencent-ils les maladies allergiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR spécifiques peuvent reconnaître des allergènes, entraînant des réactions." } }, { "@type": "Question", "name": "Les CDR sont-ils liés à des symptômes de maladies auto-immunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR mal régulés peuvent cibler des tissus sains, provoquant des symptômes." } }, { "@type": "Question", "name": "Peut-on prédire des symptômes grâce aux CDR ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des études sur les CDR peuvent aider à prédire la réponse immunitaire et les symptômes." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux CDR ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination et l'éducation sur les allergies peuvent aider à prévenir ces maladies." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être ciblés pour la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des stratégies de vaccination ciblant les CDR peuvent prévenir certaines infections." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut renforcer le système immunitaire et prévenir les maladies." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à prévenir les maladies liées aux CDR ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les risques et guider la prévention." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il la prévention des maladies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant exercice et gestion du stress, aide à prévenir les maladies." } }, { "@type": "Question", "name": "Comment les CDR sont-ils utilisés en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les CDR sont ciblés pour développer des anticorps thérapeutiques contre des maladies." } }, { "@type": "Question", "name": "Les traitements ciblant les CDR sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils montrent une efficacité dans le traitement de diverses maladies, y compris le cancer." } }, { "@type": "Question", "name": "Quels types de médicaments ciblent les CDR ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des anticorps monoclonaux et des inhibiteurs de points de contrôle immunitaire ciblent les CDR." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être modifiés pour améliorer les traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la modification des CDR peut augmenter l'affinité et la spécificité des anticorps." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ciblant les CDR ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions immunitaires indésirables et des allergies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des CDR défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR défectueux peuvent entraîner des maladies auto-immunes et des allergies." } }, { "@type": "Question", "name": "Les CDR sont-ils impliqués dans des complications infectieuses ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR inefficaces peuvent aggraver les infections et retarder la guérison." } }, { "@type": "Question", "name": "Comment les CDR affectent-ils les traitements anticancéreux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR mal ciblés peuvent réduire l'efficacité des traitements anticancéreux." } }, { "@type": "Question", "name": "Les complications liées aux CDR peuvent-elles être traitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements ciblés peuvent gérer les complications associées aux CDR." } }, { "@type": "Question", "name": "Quels sont les risques de complications lors de thérapies ciblant les CDR ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des réactions immunitaires indésirables et des effets secondaires graves." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de maladies liées aux CDR ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la génétique, l'environnement et le mode de vie augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque lié aux CDR ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des CDR et augmenter le risque de maladies." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les CDR ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer la réponse immunitaire et affecter les CDR." } }, { "@type": "Question", "name": "Les infections antérieures influencent-elles les CDR ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections passées peuvent modifier la structure et la fonction des CDR." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les CDR ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer la fonction des CDR et réduire le risque de maladies." } } ] } ] }

Sources (10000 au total)

Current treatment status of IgA nephropathy in Japan: a questionnaire survey.

In 2020, the Committee of Clinical Practical Guideline for IgA Nephropathy (IgAN) revised the clinical practice guidelines. Herein, we conducted a questionnaire survey to assess the potential discrepa... A web-based survey of members of the Japanese Society of Nephrology was conducted between November 15 and December 28, 2021.... A total of 217 members (internal physicians: 203, pediatricians: 14) responded to the questionnaire. Of these respondents, 94.0% answered that the clinical practice guidelines were referred to "always... Our questionnaire survey revealed real-world aspects of IgAN treatment in Japan....

Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.

Taxanes are widely used chemotherapeutic agents that frequently cause nail changes and have a significant impact on patients' quality of life. Despite the prevalence of taxane-induced nail toxicity, l... The questions addressed prophylactic methods, evaluation practices, and treatment approaches for various nail disorders. The questionnaires were distributed on March 1, 2022, with a response deadline ... Of the 120 questionnaires distributed, 88 (73.3%) were returned, and all of them were analyzed. The respondents included 69 physicians (32 oncologists, 26 breast surgeons, 6 dermatologists, 3 obstetri... Our survey revealed that the management of chemotherapy-induced nail changes varies in clinical practice in Japan. These findings emphasize the need for standardized management strategies and further ...

[The Questionnaire Survey of Japanese Practice and Environment for Targeted Radionuclide Therapy in 2021].

Recently, the targeted radionuclide therapy (TRT) was urgently required to adapt the practice and environment because of the implementation of novel therapeutic radiopharmaceuticals such as alpha- and... The massive questionnaire survey, 2 months from October to November 2021, was conducted among nationwide 251 facilities that have performed TRT in the past two years. The alpha- and beta- therapeutic ... The survey response rate was 69.1% (174 facilities). About 75% of these facilities reported that they either follow the guidelines or take their own measures to reduce occupational exposure. The confi... We clarified the Japanese problem for TRT practice and environment by the questionnaire survey. Our findings indicated that the Japanese guidelines and manuals for TRT were not partly followed in the ...

Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.

Telemedicine, or online medical care, has gained considerable attention worldwide. However, it has not been widely adopted in Japan, and the detailed status of received and provided online medical car... This study aims to investigate the current status of online medical care in Japan and the factors limiting its adoption from the perspective of both patients receiving and medical professionals provid... In total, 2 nationwide questionnaire surveys were conducted. The first survey, targeting both patients and healthy individuals, screened approximately 40,000 participants among 13 million people. The ... The response rates among patients and healthy individuals targeted for the screening and main surveys were 92.5% (36,998/40,000) and ˃80% (1312/1478, 88.77%; 1281/1522, 84.17%; 404/478, 84.5%; and 222... Our nationwide surveys provided insights into the current status of online medical care in Japan and simultaneously identified several problems and issues related to it, which will be useful in promot...

A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.

Despite the growing understanding of the carcinogenesis of pelvic high-grade serous carcinoma (HGSC) of the ovary and peritoneum and its precursor lesion serous tubal intraepithelial carcinoma (STIC),... A questionnaire containing 21 questions was developed to explore the clinical experience with patients with the diagnosis of STICs and the diagnostic, surgical and histopathological approaches in Germ... 131 questionnaires (response rate 24.3%) were included in this survey. 45.8% of the respondents had treated one to three STIC patients during their career. 75.6% of the respondents performed opportuni... Our survey highlights significant inconsistency in the management of patients with STIC. Prospective data are urgently needed to elucidate the clinical impact of a STIC lesion and its clinical managem...

Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey.

Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology... We set up a survey to assess the perceptions of clinical pharmacologists (CPs) regarding their roles and about clinical pharmacology courses in India. The survey was administered via a Google question... Respondents to the questionnaire were working as CPs. They were either postgraduate in pharmacology (MD pharmacology (doctor of medicine in pharmacology) 60.2%) or had a super-specialization degree in... All the CPs opined that training during the postgraduation course was not sufficient to be qualified as CP. There was no consensus among the CPs on the benefit of existing certification courses in cli...

Validation of the newly developed Advanced Practice Nurse Task Questionnaire: A national survey.

To describe psychometric validation of the newly developed Advanced Practice Nurse Task Questionnaire.... Cross-sectional quantitative study.... The development of the questionnaire followed an adapted version of the seven steps described in the guide by the Association for Medical Education in Europe. A nationwide online survey tested the con... We received 222 questionnaires between January and September 2020. The factor analysis produced a seven-factor solution as suggested in Hamric's model. However, not all item loadings aligned with the ... A precise assessment of advanced practice nurse tasks is crucial in clinical practice and in research as it may be a basis for further refinement, implementation and evaluation of roles.... The Advanced Practice Nurse Task Questionnaire is the first valid tool to assess tasks according to Hamric's model of competencies independently of the role or the setting. Additionally, it distinguis... The STARD 2015 guideline was used to report the study.... No patient or public contribution....

Attitude and Needs Toward MTM Applications of Chronic Disease in China: A Questionnaire Survey.

Chronic diseases are characterized by high incidence, long-term medication, and complex types of medication. There are also many corresponding medication therapy management (MTM) applications on the m... From August 2019 to December 2019, we created a questionnaire to have knowledge of user needs, preferences, and expectations for MTM applications among 302 chronic patients in Hunan, Guangdong, and ot... A total of 260 (86.09%) out of 302 patients the respondents were willing to use the MTM applications of chronic disease. The independent influencing factors for using the MTM applications were long-te... The participants are willing to use MTM applications of chronic disease, with a preference for the WeChat applet. Patients tended to use MTM applications if they had a long-term medication history or ...